Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors

Sharareh Gholamin, Siddhartha S. Mitra, Abdullah H. Feroze, Jie Liu, Suzana A. Kahn, Michael Zhang, Rogelio Esparza, Chase Richard, Vijay Ramaswamy, Marc Remke, Anne K. Volkmer, Stephen Willingham, Anitha Ponnuswami, Aaron McCarty, Patricia Lovelace, Theresa A. Storm, Simone Schubert, Gregor Hutter, Cyndhavi Narayanan, Pauline ChuEric H. Raabe, Griffith Harsh, Michael D. Taylor, Michelle Monje, Yoon Jae Cho, Ravi Majeti, Jens P. Volkmer, Paul G. Fisher, Gerald Grant, Gary K. Steinberg, Hannes Vogel, Michael Edwards, Irving L. Weissman, Samuel H. Cheshier

Research output: Contribution to journalArticlepeer-review

115 Scopus citations

Fingerprint Dive into the research topics of 'Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences